Akèy › Metiyè › Medical Scientists, Except Epidemiologists › Redwood City, CA
Medical Scientists, Except Epidemiologists nan Redwood City, CA: Salè H-1B
27 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Redwood City, CA. Salè baz medyàn ofri $135,000; mwatye mitan $125,000–$153,000.
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $95,420 |
| Nivo II (kalifye) | $137,500 |
| Nivo III (eksperyans) | $162,000 |
| Nivo IV (plen kompetans) | $137,987 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Revolution Medicines, Inc. | 5 | $140,000 |
| Synthego Corporation | 3 | $125,000 |
| Seer, Inc. | 2 | $120,139 |
| The Leland Stanford, Jr University | 2 | $103,325 |
| Retro Biosciences, Inc. | 2 | $176,232 |
| Programmable Medicine Operating Company | 2 | $162,000 |
| Synthego Holdings LLC | 2 | $146,000 |
| Adverum Biotechnologies, Inc. | 1 | $140,974 |
| Ascendis Pharma, Inc. | 1 | $135,000 |
| Eyconis, Inc. | 1 | $142,000 |
| Nevro Corp | 1 | $130,250 |
| EditCo Bio, Inc. | 1 | $99,840 |
| Whiterabbit. AI, Inc. | 1 | $190,000 |
| Arcellx, Inc. | 1 | $185,000 |
| Pheast Therapeutics, Inc | 1 | $134,000 |
| Integrated Biosciences, Inc. | 1 | $110,000 |
Tit travay
- Scientist, Formulation Development2
- Quality Control Scientist2
- Clinical Trial Manager2
- Sr. Scientist2
- Senior Scientist, Quality Control2
- Principal Scientist, Pharmaceutical Development1
- Senior Scientist I - Cancer Pharmacology1
- Research Associate II - Cancer Pharmacology1
- Analytical Scientist1
- Senior Research Associate1
- Clinical PK Manager1
- Senior Research Engineer1
- Postdoctoral Research Affiliate1
- Instructor1
- Senior Scientist II, Cancer Pharmacology1
Pwonse H-1B nan Redwood City, CA →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).